Haemonetics Corporation Capital Reinvestment Ratio
Haemonetics Corporation capital reinvestment ratio. Haemonetics Corporation (HAE) has a Capital Reinvestment Ratio of 0.25x as of March 2026, meaning it reinvests 0% of its operating cash flow ($70.94 Million) in capital expenditures ($17.66 Million). Check Haemonetics Corporation (HAE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Haemonetics Corporation (1992–2026)
Capital reinvestment ratio of Haemonetics Corporation from 1992 to 2026. This chart tracks Haemonetics Corporation's Capital Reinvestment Ratio across 35 annual periods. Also explore Haemonetics Corporation annual equity growth to track the company's year-over-year net asset growth rate.
Haemonetics Corporation Capital Reinvestment Ratio by Year (1992–2026)
Haemonetics Corporation capital reinvestment ratio by year from 1992 to 2026. For the full cash flow conversion analysis, see HAE operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.11x | $293.22 Million | $32.78 Million | ▼ -48.3% |
| 2025 | 0.22x | $181.72 Million | $39.28 Million | ▼ -40.7% |
| 2024 | 0.36x | $181.75 Million | $66.30 Million | ▼ -9.6% |
| 2023 | 0.40x | $273.06 Million | $110.19 Million | ▼ -28.0% |
| 2022 | 0.56x | $172.26 Million | $96.51 Million | ▲ +64.6% |
| 2021 | 0.34x | $108.81 Million | $37.04 Million | ▲ +10.5% |
| 2020 | 0.31x | $158.22 Million | $48.76 Million | ▼ -58.7% |
| 2019 | 0.75x | $159.28 Million | $118.96 Million | ▲ +120.0% |
| 2018 | 0.34x | $220.35 Million | $74.80 Million | ▼ -28.8% |
| 2017 | 0.48x | $159.74 Million | $76.14 Million | ▼ -43.3% |
| 2016 | 0.84x | $121.86 Million | $102.41 Million | ▼ -12.6% |
| 2015 | 0.96x | $127.18 Million | $122.22 Million | ▲ +82.1% |
| 2014 | 0.53x | $139.52 Million | $73.65 Million | ▼ -27.8% |
| 2013 | 0.73x | $85.07 Million | $62.19 Million | ▲ +58.5% |
| 2012 | 0.46x | $115.32 Million | $53.20 Million | ▲ +22.0% |
| 2011 | 0.38x | $123.45 Million | $46.67 Million | ▼ -12.3% |
| 2010 | 0.43x | $130.67 Million | $56.30 Million | ▼ -11.1% |
| 2009 | 0.48x | $116.36 Million | $56.38 Million | ▼ -34.9% |
| 2008 | 0.74x | $77.67 Million | $57.79 Million | ▲ +50.0% |
| 2007 | 0.50x | $83.56 Million | $41.46 Million | ▲ +15.5% |
| 2006 | 0.43x | $85.62 Million | $36.77 Million | ▲ +74.5% |
| 2005 | 0.25x | $71.21 Million | $17.53 Million | ▲ +32.5% |
| 2004 | 0.19x | $74.61 Million | $13.86 Million | ▼ -40.1% |
| 2003 | 0.31x | $43.67 Million | $13.54 Million | ▼ -53.7% |
| 2002 | 0.67x | $32.24 Million | $21.60 Million | ▲ +33.9% |
| 2001 | 0.50x | $61.01 Million | $30.54 Million | ▲ +14.8% |
| 2000 | 0.44x | $53.47 Million | $23.32 Million | ▼ -34.7% |
| 1999 | 0.67x | $33.70 Million | $22.50 Million | ▼ -33.2% |
| 1998 | 1.00x | $20.40 Million | $20.40 Million | ▼ -16.6% |
| 1997 | 1.20x | $26.70 Million | $32.00 Million | ▲ +233.4% |
| 1996 | 0.36x | $54.80 Million | $19.70 Million | ▼ -77.5% |
| 1995 | 1.60x | $15.60 Million | $24.90 Million | ▲ +88.2% |
| 1994 | 0.85x | $27.00 Million | $22.90 Million | ▲ +73.0% |
| 1993 | 0.49x | $35.90 Million | $17.60 Million | ▼ -19.2% |
| 1992 | 0.61x | $18.80 Million | $11.40 Million | — |